Frontiers in Computational Neuroscience,
Год журнала:
2025,
Номер
19
Опубликована: Март 12, 2025
Early
prediction
of
Alzheimer's
disease
(AD)
is
crucial
to
improving
patient
quality
life
and
treatment
outcomes.
However,
current
predictive
methods
face
challenges
such
as
insufficient
multimodal
information
integration
the
high
cost
PET
image
acquisition,
which
limit
their
effectiveness
in
practical
applications.
To
address
these
issues,
this
paper
proposes
an
innovative
model,
AD-Diff.
This
model
significantly
improves
AD
accuracy
by
integrating
images
generated
through
a
diffusion
process
with
cognitive
scale
data
other
modalities.
Specifically,
AD-Diff
consists
two
core
components:
ADdiffusion
module
Mamba
Classifier.
The
uses
3D
generate
high-quality
images,
are
then
fused
MRI
tabular
provide
input
for
Multimodal
Experimental
results
on
OASIS
ADNI
datasets
demonstrate
that
performs
exceptionally
well
both
long-term
short-term
tasks,
reliability.
These
highlight
significant
advantages
handling
complex
medical
information,
providing
effective
tool
early
diagnosis
personalized
disease.
Artificial
Intelligence
(AI)
describes
computer
systems
able
to
perform
tasks
that
normally
require
human
intelligence,
such
as
visual
perception,
speech
recognition,
decision-making,
and
language
translation.
Examples
of
AI
techniques
are
machine
learning,
neural
networks,
deep
learning.
can
be
applied
in
many
different
areas,
econometrics,
biometry,
e-commerce,
the
automotive
industry.
In
recent
years,
has
found
its
way
into
healthcare
well,
helping
doctors
make
better
decisions
(“clinical
decision
support”),
localizing
tumors
magnetic
resonance
images,
reading
analyzing
reports
written
by
radiologists
pathologists,
much
more.
However,
one
big
risk:
it
perceived
a
“black
box”,
limiting
trust
reliability,
which
is
very
issue
an
area
mean
life
or
death.
As
result,
term
Explainable
(XAI)
been
gaining
momentum.
XAI
tries
ensure
algorithms
(and
resulting
decisions)
understood
humans.
this
narrative
review,
we
will
have
look
at
some
central
concepts
XAI,
describe
several
challenges
around
healthcare,
discuss
whether
really
help
advance,
for
example,
increasing
understanding
trust.
Finally,
alternatives
increase
discussed,
well
future
research
possibilities
XAI.
Journal of Imaging,
Год журнала:
2024,
Номер
10(4), С. 81 - 81
Опубликована: Март 28, 2024
Computer
vision
(CV),
a
type
of
artificial
intelligence
(AI)
that
uses
digital
videos
or
sequence
images
to
recognize
content,
has
been
used
extensively
across
industries
in
recent
years.
However,
the
healthcare
industry,
its
applications
are
limited
by
factors
like
privacy,
safety,
and
ethical
concerns.
Despite
this,
CV
potential
improve
patient
monitoring,
system
efficiencies,
while
reducing
workload.
In
contrast
previous
reviews,
we
focus
on
end-user
CV.
First,
briefly
review
categorize
other
(job
enhancement,
surveillance
automation,
augmented
reality).
We
then
developments
hospital
setting,
outpatient,
community
settings.
The
advances
monitoring
delirium,
pain
sedation,
deterioration,
mechanical
ventilation,
mobility,
surgical
applications,
quantification
workload
hospital,
for
events
outside
highlighted.
To
identify
opportunities
future
also
completed
journey
mapping
at
different
levels.
Lastly,
discuss
considerations
associated
with
outline
processes
algorithm
development
testing
limit
expansion
healthcare.
This
comprehensive
highlights
ideas
expanded
use
Frontiers in Computer Science,
Год журнала:
2025,
Номер
6
Опубликована: Янв. 10, 2025
Alzheimer's
disease
(AD)
is
a
type
of
brain
that
makes
it
hard
for
someone
to
perform
daily
tasks.
Early
diagnosis
and
classification
the
condition
are
thought
be
essential
study
areas
due
speedy
progression
in
people
living
with
dementia
absence
precise
diagnostic
procedures.
One
main
aims
researchers
correctly
identify
early
stages
AD
so
can
prevented
or
significantly
reduced.
The
objective
current
review
thoroughly
examine
most
recent
work
on
detection
using
deep
learning
(DL)
approach.
This
paper
examined
purpose
an
AD,
various
neuroimaging
modalities,
pre-processing
methods
were
employed,
maintenance
data,
used
classifying
from
magnetic
resonance
imaging
(MRI)
images,
publicly
available
datasets,
data
fed
into
models.
A
comparative
analysis
different
DL
techniques
performed.
Further,
discussed
challenges
involved
detection.
Abstract
Clinical
diagnosis
of
Alzheimer’s
disease
(AD)
is
usually
made
after
symptoms
such
as
short-term
memory
loss
are
exhibited,
which
minimizes
the
intervention
and
treatment
options.
The
existing
screening
techniques
cannot
distinguish
between
stable
MCI
(sMCI)
cases
(i.e.,
patients
who
do
not
convert
to
AD
for
at
least
three
years)
progressive
(pMCI)
in
years
or
sooner).
Delayed
also
disproportionately
affects
underrepresented
socioeconomically
disadvantaged
populations.
significant
positive
impact
an
early
solution
across
diverse
ethno-racial
demographic
groups
well-known
recognized.
While
advancements
high-throughput
technologies
have
enabled
generation
vast
amounts
multimodal
clinical,
neuroimaging
datasets
related
AD,
most
methods
utilizing
these
data
sets
diagnostic
purposes
found
their
way
clinical
settings.
To
better
understand
landscape,
we
surveyed
major
preprocessing,
management,
traditional
machine-learning
(ML),
deep
learning
(DL)
used
diagnosing
using
structural
magnetic
resonance
imaging
(sMRI),
functional
(fMRI),
positron
emission
tomography
(PET).
Once
had
a
good
understanding
available,
conducted
study
assess
reproducibility
generalizability
open-source
ML
models.
Our
evaluation
shows
that
models
show
reduced
when
different
cohorts
modality
while
controlling
other
computational
factors.
paper
concludes
with
discussion
challenges
plague
biomarker
discovery.
Frontiers in Aging Neuroscience,
Год журнала:
2023,
Номер
15
Опубликована: Апрель 18, 2023
Alzheimer’s
disease
(AD)
is
a
progressive,
neurodegenerative
disorder
that
affects
memory,
thinking,
behavior,
and
other
cognitive
functions.
Although
there
no
cure,
detecting
AD
early
important
for
the
development
of
therapeutic
plan
care
may
preserve
function
prevent
irreversible
damage.
Neuroimaging,
such
as
magnetic
resonance
imaging
(MRI),
computed
tomography
(CT),
positron
emission
(PET),
has
served
critical
tool
in
establishing
diagnostic
indicators
during
preclinical
stage.
However,
neuroimaging
technology
quickly
advances,
challenge
analyzing
interpreting
vast
amounts
brain
data.
Given
these
limitations,
great
interest
using
artificial
Intelligence
(AI)
to
assist
this
process.
AI
introduces
limitless
possibilities
future
diagnosis
AD,
yet
still
resistance
from
healthcare
community
incorporate
clinical
setting.
The
goal
review
answer
question
whether
should
be
used
conjunction
with
AD.
To
question,
possible
benefits
disadvantages
are
discussed.
main
advantages
its
potential
improve
accuracy,
efficiency
radiographic
data,
reduce
physician
burnout,
advance
precision
medicine.
include
generalization
data
shortage,
lack
vivo
gold
standard,
skepticism
medical
community,
bias,
concerns
over
patient
information,
privacy,
safety.
challenges
present
fundamental
must
addressed
when
time
comes,
it
would
unethical
not
use
if
can
health
outcome.
International Journal of Cognitive Computing in Engineering,
Год журнала:
2024,
Номер
5, С. 307 - 315
Опубликована: Янв. 1, 2024
The
integration
of
Artificial
Intelligence
(AI)
and
Wearable
Internet
Things
(WIoT)
for
mental
health
detection
is
a
promising
area
research
with
the
potential
to
revolutionize
monitoring
diagnosis.
Since
early
diseases,
i.e.,
depression,
great
importance
diagnosis
treatment,
fast
convenient
way
urgently
needed.
Traditional
diagnostic
methods
are
time-consuming,
laborious,
over-subjective,
easily
lead
misdiagnosis.
advance
in
information
techniques
wearable
devices
brings
innovation
disease
detection.
Therefore,
this
article
first
compares
intelligent
depression
traditional
illustrate
significance
then
analyzes
opportunities
device.
Then
we
provide
specific
psychophysiological
data
measured
by
introduce
relevant
datasets
An
illustrative
example
sleep
presented
discussed
our
proposed
ensemble
method
has
improved
nearly
10%
baselines.
Analytical
results
demonstrate
using
device-measured
detect
intelligently.
Reviews in the Neurosciences,
Год журнала:
2023,
Номер
34(6), С. 649 - 670
Опубликована: Фев. 2, 2023
Abstract
Alzheimer’s
disease
(AD)
is
a
degenerative
disorder
that
leads
to
progressive,
irreversible
cognitive
decline.
To
obtain
an
accurate
and
timely
diagnosis
detect
AD
at
early
stage,
numerous
approaches
based
on
convolutional
neural
networks
(CNNs)
using
neuroimaging
data
have
been
proposed.
Because
3D
CNNs
can
extract
more
spatial
discrimination
information
than
2D
CNNs,
they
emerged
as
promising
research
direction
in
the
of
AD.
The
aim
this
article
present
current
state
art
CNN
models
modalities,
focusing
architectures
classification
methods
used,
highlight
potential
future
topics.
give
reader
better
overview
content
mentioned
review,
we
briefly
introduce
commonly
used
imaging
datasets
fundamentals
architectures.
Then
carefully
analyzed
existing
studies
diagnosis,
which
are
divided
into
two
levels
according
their
inputs:
subject-level
patch-level
highlighting
contributions
significance
field.
In
addition,
review
discusses
key
findings
challenges
from
highlights
lessons
learned
roadmap
for
research.
Finally,
summarize
paper
by
presenting
some
major
findings,
identifying
open
challenges,
pointing
out
directions.